Compared to <i>ETV6::RUNX1</i>-positive ALL, patients with <i>ETV6::RUNX1</i>-like ALL are younger, have higher white blood cell counts at diagnosis, and have an inferior early treatment response. Here, RUNX1 is linked to acute lymphoblastic leukemia.